615 Targeted immune cell activation by systemic delivery of toll-like receptor 9 agonist antibody conjugates induce potent anti-tumor immunity

• Ons Harrabi,
• Amy Chen,
• Emma Sangalang,
• Laura Doyle,
• Danielle Fontaine,
• Bora Han,
• Curt Bradshaw,
• Jaume Pons,
• Janet Sim,
• Tracy Kuo,
• Hong Wan

Affiliations

Ons Harrabi

1Tallac Therapeutics, Burlingame, CA, USA

Amy Chen

1Tallac Therapeutics, Burlingame, CA, USA

Emma Sangalang

1Tallac Therapeutics, Burlingame, CA, USA

Laura Doyle

1Tallac Therapeutics, Burlingame, CA, USA

Danielle Fontaine

1Tallac Therapeutics, Burlingame, CA, USA

Bora Han

1Tallac Therapeutics, Burlingame, CA, USA

Curt Bradshaw

2Arrowhead Pharmaceuticals, Pasadena, CA, USA

Jaume Pons

3ALX Oncology, Inc., Burlingame, CA, USA

Janet Sim

1Tallac Therapeutics, Burlingame, CA, USA

Tracy Kuo

1Tallac Therapeutics, Burlingame, CA, USA

Hong Wan

1Tallac Therapeutics, Burlingame, CA, USA